No­vo Nordisk’s glob­al obe­si­ty leader is mov­ing on; Flag­ship biotech gets CEO from Schol­ar Rock

Leo Phar­ma is do­ing an ex­ten­sive re­vamp of its lead­er­ship team as it splits prod­uct strat­e­gy and in­ter­na­tion­al op­er­a­tions in­to two sep­a­rate di­vi­sions. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.